Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumors × amivantamab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Squamous Cell Carcinoma of Head and Neck 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Locally Recurrent Skin Squamous Cell Carcinoma 1

Interventions

pembrolizumab 4 Cetuximab 4 olaparib 2 atezolizumab 2 Trastuzumab 2 Docetaxel 2 tocilizumab 1 spartalizumab 1 ribociclib 1 pralsetinib 1 pertuzumab 1 lenvatinib 1 ipatasertib 1 inavolisib 1 entrectinib 1 encorafenib 1 dapagliflozin 1 cemiplimab 1 brigimadlin 1 binimetinib 1 alectinib 1 adagrasib 1 Rifampin 1 Pemetrexed 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡